Neuroendocrine tumors involving the gastroenteropancreatic tract: A clinicopathological evaluation of 773 cases

Clinics

Volumn 66, Issue 10, 2011, Pages 1671-1675

  Estrozi, Bruna ^a   Bacchi, Carlos E ^a  

^a Consultoria em Patologia ^*  (Brazil)

Author keywords

Brazil; Carcinoid; Carcinomas; Gastroenteropancreatic system; Neuroendocrine tumors

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CHILD; FEMALE; HUMAN; INTESTINE TUMOR; MALE; MIDDLE AGED; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SEX RATIO; STOMACH TUMOR; TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; CHILD; FEMALE; HUMANS; INTESTINAL NEOPLASMS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; STOMACH NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 80054766997     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011001000002     Document Type: Article

References (36)

1. Modlin IM, Oberg K, Jensen RT, de Herder WW, Thakker RV, Caplin M, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61-72, doi: 10.1016/S1470-2045(07)70410-2.
2. Modlin IM, Lye KD, Kidd MA. 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-59, doi: 10.1002/cncr.11105.
3. Yunes RN. Neuroendocrine tumors: a registry of 1,000 patients. Rev Assoc Med Bras. 2008;54:305-7, doi: 10.1590/S0104-42302008000400014.
4. Bosman F, Carneiro F, Hruban R, Theise N, eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010.
5. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813-29, doi: 10.1002/(SICI)1097-0142(19970215)79:4<813:AID-CNCR19>3.0.CO;2-2.
6. Godwin JD 2nd. Carcinoid tumors: An analysis of 2,837 cases. Cancer. 1975;36:560-9, doi: 10.1002/1097-0142(197508)36:2<560::AID-CNCR 2820360235>3.0.CO;2-4.
7. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117-22, doi: 10.1097/01.sla.0000129342.67174.67.
8. Burke AB, Shekitka KM, Sobin LH. Small cell carcinomas of the large intestine. Am J Clin Pathol. 1991;95:315-21.
9. Burke M, Shepherd N, Mann CV. Carcinoid tumours of the rectum and anus. Br J Surg. 1987;74:358-61, doi: 10.1002/bjs.1800740509.
10. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
11. Jetmore AB, Ray JE, Gathright JB Jr, McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum. 1992;35:717-25, doi: 10.1007/BF02050318.
12. Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumours of the small intestine. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:77-82.
13. Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumours of the stomach. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:53-7.
14. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2009.
15. Heitz PU, Komminoth P, Perren A, Klimstra DS, Dayal Y, Bordi C, et al. Pancreatic endocrine tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004:177-82.
16. Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, et al. European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401, doi: 10.1007/s00428-006-0250-1.
17. Rindi G, Klöppel G, Couvelard A, Komminoth P, Körner M, Lopes JM, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007;451:757-62, doi: 10.1007/s00428-007-0452-1.
18. Safatle-Ribeiro AV, Ribeiro U Jr, Corbett CE, Iriya K, Kobata CH, Sakai P, et al. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors. Eur J Gastroenterol Hepatol. 2007;19:21-8, doi: 10.1097/01.meg.0000250582.30737.bd.
19. Machado MC, Machado MA, Perini MV, Herman P, Jukemura J, Leite KR, et al. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior? Hepatogastroenterology. 2008;55:708-10.
20. Dias AR, Sallum RA, Zalc N, Ctenas BB, Ribeiro U, Cecconello I. Squamous cell carcinoma and neuroendocrine carcinoma colliding in the esophagus. Clinics. 2010;65:114-7, doi: 10.1590/S1807-59322010000100018.
21. La Rosa S, Sessa F, Capella C, Riva C, Leone BE, Klersy C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 1996;429:323-33.
22. Moyana TN, Xiang J, Senthilselvan A, Kulaga A. The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity. Arch Pathol Lab Med. 2000;124:570-6.
23. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532-42, doi: 10.1016/S0016-5085(99)70174-5.
24. von Herbay A, Sieg B, Schurmann G, Hofmann WJ, Betzler M, Otto HF. Proliferative activity of neuroendocrine tumours of the gastroenteropancreatic endocrine system: DNA flow cytometric and immunohistological investigations. Gut. 1991;32:949-53, doi: 10.1136/gut.32.8.949.
25. Erickson LA, Lloyd RV. Practical markers used in the diagnosis of endocrine tumors. Adv Anat Pathol. 2004;11:175-89.
26. Modlin IM, Shapiro MD, Kidd M, Eick G. Siegfried Oberndorfer and the evolution of carcinoid disease. Arch Surg. 2007;142:187-97, doi: 10.1001/archsurg.142.2.187.
27. Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004;80(Suppl 1):3-7, doi: 10.1159/000080731.
28. Attar BM, Levendoglu H, Rhee H. Small cell carcinoma of the esophagus. Report of three cases and review of the literature. Dig Dis Sci. 1990;35:145-52, doi: 10.1007/BF01537236.
29. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol. 2003;99:23-32, doi: 10.1046/j.1572-0241.2003.04027.x.
30. Yildiz O, Ozguroglu M, Yanmaz T, Turna H, Serdengecti S, Dogusoy G. Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center. Med Oncol. 2010;27:1050-6, doi: 10.1007/s12032-009-9332-7.
31. Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer. 2001;15: 92:2204-10, doi: 10.1002/1097-0142(20011015)92:8<2204:AID-CNCR1564>3.0.CO;2-R.
32. Moertel CG, Dockerty MB, Judd ES. Carcinoid tumors of the vermiform appendix. Cancer. 1968;21:270-8, doi: 10.1002/1097-0142(196802)21:2<270::AID-CNCR2820210217>3.0.CO;2-9.
33. Roggo A, Wood WC, Ottinger LW. Carcinoid tumors of the appendix. Ann Surg. 1993;217:385-90, doi: 10.1097/00000658-199304000-00010.
34. Neves GR, CHachap P, Sredni ST, Viana CR, Mendes WL. Childhood carcinoid tumors: description of a case series in a Brazilian cancer center. Sao Paulo Med J. 2006;124:21-5, doi: 10.1590/S1516-31802006000100005.
35. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon, Frances: IARC Pres; 2000.
36. Lin X, Saad RS, Luckasevic TM, Silverman JF, Liu Y. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Appl Immunohistochem Mol Morphol. 2007;15:407-14.